IN3 West 2010

Eye Sonix

First Time Presenter

Long Beach, CA

Developing a new method of treating open angle glaucoma using a non-invasive ultrasound device.

Soft Tissue Regeneration, Inc.

Stamford, CT

Soft Tissue Regeneration, Inc. has developed a biocompatible and biodegradable scaffold to regenerate the anterior cruciate ligament (“ACL”) of the knee.

NeoVista, Inc.

Fremont, CA

NeoVista, Inc. has a minimally invasive surgical technology that uses ionizing radiation to treat Age-Related Macular Degeneration (ARMD).

SquareOne Inc.

First Time Presenter

Mountain View, CA

SquareOne is commercializing a highly differentiated aorto-ostial stent and delivery platform with strong IP for both peripheral and coronary application.

Orthosensor, Inc.

First Time Presenter

Sunrise, FL

Orthosensor, Inc. is an early stage medical device company located in Sunrise Florida that is developing “Intelligent Orthopedic Devices” that will address the growing clinical and economic cost of orthopedic implant failure and osteoporosis.

Biomedica

First Time Presenter

Brooklyn, NY

BIOMEDICA Management Corp Focusing on next generation biologic devices for high volume hemorrhage and sepsis.

Vertos Medical

Aliso Viejo, CA

Pioneered the MILD™ (Minimally Invasive Lumbar Decompression) procedure which may be performed in conventional operating rooms or interventional radiology suites with fluoroscopic imaging.

CardioMag Imaging, Inc.

Schenectady, NY

Non-invasive devices to identify patients with coronary artery disease and other life threatening cardiovascular conditions.

CytoPherx, Inc.

First Time Presenter

Ann Arbor, MI

Inflammation-based diseases and conditions with a proprietary selective cytopheresis system.

Freedom Meditech Inc.

La Jolla, CA

Developing and commercializing 2 non-invasive ophthalmic medical device products for diabetes screening and daily diabetes glucose monitoring.

D.S. Biomedical, LLC

First Time Presenter

Belmont, WA, Australia

The product is an Electronic Biofeedback stimulation device that analyzes and also treats. There are five different units, two devices have patents pending and there are seven registered trademarks.

GT Urological, LLC

First Time Presenter

Minneapolis, MN

GT Urological, LLC (GTU) is an emerging, clinical stage, medical device company focused on developing proprietary products for the urinary incontinence market.

Capnia, Inc.

First Time Presenter

Palo Alto, CA

Capnia, located in Palo Alto, California, is developing a novel medical device for the symptomatic treatment of rhinitis (allergies).

LumaMed

First Time Presenter

Alpharetta, GA

LumaMed provides a web based service platform enabled by a proprietary imaging technology for the remote evaluation of skin cancer.

CeQur, Ltd.

First Time Presenter

Hellerup, Denmark

CeQur's lead product candidate is a small, wearable insulin delivery device that delivers both basal and bolus doses subcutaneously. Its simple and discrete design enables patients to more easily comply with insulin regimens and experience the benefits of intensive insulin therapy.

EndoGastric Solutions, Inc.

First Time Presenter

Redmond, WA

Minimally invasive surgical procedures for the treatment of gastroenterological diseases.

e-Zassi, LLC

Fernandina Beach, FL

e-Zassi has launched the first software service in the world that materially speeds medical device industry transaction times while also providing automated and predictive device technology diligence and confidentiality protection for all parties.

PEAK Surgical, Inc.

Palo Alto, CA

Technology provides the precision of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral tissue damage.

PortaScience, Inc.

Moorestown, NJ

Our core technologies enable us to develop non-instrumented devices, for a broad range of diagnostic and monitoring tests which are accurate and low cost.

Orasi Medical

First Time Presenter

Edna, MN

Orasi Medical, a recent university spinoff that's developing technology to help quickly diagnose neurological diseases like Alzheimer's.

Infusion Innovations, Inc.

First Time Presenter

La Jolla, CA

Founded in 2006, I3 has a strong proprietary portfolio of products ranging from needle-less injection site connectors, to safety syringes, and biodiagnostic sampling devices.

PolyMedix, Inc.

Radnor, PA

PolyMedix is developing novel, first in class therapies for serious, life threatening, acute disorders.

IVDiagnostics, LLC

First Time Presenter

West Lafayette, IN

Develop, test and market more effective diagnostic tools for addressing rare circulating tumor cells.

VitalWear, Inc.

South San Francisco, CA

Provides affordable thermal systems that are portable, easy-to-use and comfortable to wear.

EndoSphere Surgical, Inc.

First Time Presenter

Brookline, MA

EndoSphere Surgical, Inc. is developing a novel platform technology aimed at advances in micro-laparoscopic surgery that improves hand-eye coordination resulting in improved cosmetic benefits using one fewer surgical port.

Freshmedx

First Time Presenter

Salt Lake City, UT

Freshmedx based in Salt Lake City, Utah has developed an innovative new medical diagnostic system for the early detection of lung cancer.

Magellan Spine Technologies

First Time Presenter

Irvine, CA

Magellan is developing minimally invasive lumbar annular repair technologies to prevent disc reherniation and interrupt disc degeneration.

Graft-Loc

Englewood, CO

Graft-Loc is a debt-free, early stage device company focused on vascular connections for use in CABG & vascular surgeries. Graft-Loc's patented device creates a reliable anastomosis to any graft site.

Portable Health Device

First Time Presenter

Orlando, FL

The Portable Health Device is a very robust patient, provider and insurer application on a simple USB flash drive.

Control Medical Technology

First Time Presenter

Park City, UT

510K cleared platform with issued patents that bridges the gap between low-tech aspiration and complex electromechanical aspiration systems for use in thrombus removal, rotational vacuum assisted biopsy, tissue resection, and spinal disc decompression.

EndoPhlebex Technologies, Inc.

First Time Presenter

Bedford, New Hampshire

EndoPhlebex Technologies, Inc. offers varicose vein stripping under direct vision for ablation of the diseased saphenous vein in a kit that reduces trauma, minimizes bleeding and expects improved clinical outcomes.

Altea Therapeutics

First Time Presenter

Atlanta, GA

Altea Therapeutics is a private specialty pharmaceutical company developing and commercializing pharmaceutical products based on a new class of transdermal patches that deliver therapeutic levels of water-soluble biological drugs and low molecular weight drugs that otherwise would be administered by needle injection or infusion.

MenRx Surgical, LLC

First Time Presenter

Jacksonville, FL

MenRx Surgical markets the Pro-Vas Occlusion Device which provides men seeking a permanent form of contraception with a less-invasive alternative to vasectomy.

Avantis Medical Systems, Inc.

First Time Presenter

Sunnyvale, CA

A commercial stage visualization technology company focused on delivering cost-effective solutions for the improved detection and prevention of cancer in the gastrointestinal (GI) tract.

Apogee Aesthetic Technologies

First Time Presenter

Bryn Mawr, PA

Novel minimally invasive device for midface lift and other lift procedures.

GeneEx, Inc.

First Time Presenter

Hialeah, FL

GeneEx is developing rapid, point-of-care saliva tests for infectious diseases capable of detecting virulence markers produced only during active infections.

Epinex Diagnostics, Inc.

First Time Presenter

Irvine, CA

Epinex specializes in the development of innovative rapid tests that target major deficiencies in existing healthcare markets. The G1A™ is a patented, rapid test that uses glycated albumin to monitor diabetes more effectively.

Thermimage, Inc.

First Time Presenter

Taylorsville, UT

A noninvasive diagnostic medical device that replaces the current traumatic procedure used to detect pediatric VUR (urinary reflux) and prevent kidney damage in 4MM children annually.